nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—MAPT—Docetaxel—pancreatic cancer	0.18	0.26	CbGbCtD
Lansoprazole—CYP1B1—Tamoxifen—pancreatic cancer	0.0506	0.0732	CbGbCtD
Lansoprazole—CYP1B1—Erlotinib—pancreatic cancer	0.043	0.0623	CbGbCtD
Lansoprazole—CYP1B1—Docetaxel—pancreatic cancer	0.0285	0.0412	CbGbCtD
Lansoprazole—CYP1A1—Dacarbazine—pancreatic cancer	0.0279	0.0404	CbGbCtD
Lansoprazole—ABCG2—Tamoxifen—pancreatic cancer	0.024	0.0348	CbGbCtD
Lansoprazole—ATP4A—gastric juice—pancreatic cancer	0.0231	0.674	CbGeAlD
Lansoprazole—CYP1A1—Tamoxifen—pancreatic cancer	0.0222	0.0321	CbGbCtD
Lansoprazole—CYP1B1—Doxorubicin—pancreatic cancer	0.0212	0.0307	CbGbCtD
Lansoprazole—ABCG2—Erlotinib—pancreatic cancer	0.0204	0.0296	CbGbCtD
Lansoprazole—CYP1A1—Erlotinib—pancreatic cancer	0.0189	0.0273	CbGbCtD
Lansoprazole—ABCG2—Irinotecan—pancreatic cancer	0.0185	0.0267	CbGbCtD
Lansoprazole—ABCG2—Fluorouracil—pancreatic cancer	0.0177	0.0257	CbGbCtD
Lansoprazole—ABCG2—Docetaxel—pancreatic cancer	0.0135	0.0196	CbGbCtD
Lansoprazole—ABCG2—Sunitinib—pancreatic cancer	0.0135	0.0195	CbGbCtD
Lansoprazole—CYP2C8—Tamoxifen—pancreatic cancer	0.0128	0.0185	CbGbCtD
Lansoprazole—CYP1A2—Dacarbazine—pancreatic cancer	0.0125	0.018	CbGbCtD
Lansoprazole—CYP2C8—Erlotinib—pancreatic cancer	0.0109	0.0158	CbGbCtD
Lansoprazole—CYP2C19—Tamoxifen—pancreatic cancer	0.0107	0.0156	CbGbCtD
Lansoprazole—ABCG2—Doxorubicin—pancreatic cancer	0.0101	0.0146	CbGbCtD
Lansoprazole—CYP1A2—Tamoxifen—pancreatic cancer	0.00992	0.0144	CbGbCtD
Lansoprazole—CYP2C8—Fluorouracil—pancreatic cancer	0.00944	0.0137	CbGbCtD
Lansoprazole—CYP2C9—Tamoxifen—pancreatic cancer	0.00893	0.0129	CbGbCtD
Lansoprazole—ABCB1—Tamoxifen—pancreatic cancer	0.00867	0.0126	CbGbCtD
Lansoprazole—CYP1A2—Erlotinib—pancreatic cancer	0.00843	0.0122	CbGbCtD
Lansoprazole—CYP2D6—Tamoxifen—pancreatic cancer	0.00817	0.0118	CbGbCtD
Lansoprazole—ABCB1—Gemcitabine—pancreatic cancer	0.00747	0.0108	CbGbCtD
Lansoprazole—ABCB1—Erlotinib—pancreatic cancer	0.00737	0.0107	CbGbCtD
Lansoprazole—CYP1A2—Fluorouracil—pancreatic cancer	0.00731	0.0106	CbGbCtD
Lansoprazole—CYP2D6—Erlotinib—pancreatic cancer	0.00695	0.0101	CbGbCtD
Lansoprazole—ABCB1—Irinotecan—pancreatic cancer	0.00666	0.00964	CbGbCtD
Lansoprazole—CYP2C9—Fluorouracil—pancreatic cancer	0.00658	0.00953	CbGbCtD
Lansoprazole—CYP3A4—Tamoxifen—pancreatic cancer	0.0052	0.00752	CbGbCtD
Lansoprazole—ABCB1—Docetaxel—pancreatic cancer	0.00488	0.00706	CbGbCtD
Lansoprazole—ABCB1—Sunitinib—pancreatic cancer	0.00486	0.00703	CbGbCtD
Lansoprazole—CYP3A4—Erlotinib—pancreatic cancer	0.00442	0.00639	CbGbCtD
Lansoprazole—CYP3A4—Irinotecan—pancreatic cancer	0.00399	0.00577	CbGbCtD
Lansoprazole—ABCB1—Doxorubicin—pancreatic cancer	0.00364	0.00527	CbGbCtD
Lansoprazole—CYP2D6—Doxorubicin—pancreatic cancer	0.00343	0.00496	CbGbCtD
Lansoprazole—ATP4B—digestive system—pancreatic cancer	0.00323	0.0945	CbGeAlD
Lansoprazole—CYP3A4—Docetaxel—pancreatic cancer	0.00292	0.00423	CbGbCtD
Lansoprazole—CYP3A4—Sunitinib—pancreatic cancer	0.00291	0.00421	CbGbCtD
Lansoprazole—CYP3A4—Doxorubicin—pancreatic cancer	0.00218	0.00315	CbGbCtD
Lansoprazole—CYP4A11—digestive system—pancreatic cancer	0.00175	0.051	CbGeAlD
Lansoprazole—ATP4A—digestive system—pancreatic cancer	0.00141	0.0411	CbGeAlD
Lansoprazole—CYP2C18—digestive system—pancreatic cancer	0.00116	0.0338	CbGeAlD
Lansoprazole—CYP1B1—digestive system—pancreatic cancer	0.00056	0.0164	CbGeAlD
Lansoprazole—CYP2C19—digestive system—pancreatic cancer	0.000492	0.0144	CbGeAlD
Lansoprazole—CYP1A2—digestive system—pancreatic cancer	0.000401	0.0117	CbGeAlD
Lansoprazole—CYP1A1—digestive system—pancreatic cancer	0.000396	0.0116	CbGeAlD
Lansoprazole—CYP2C9—digestive system—pancreatic cancer	0.000381	0.0111	CbGeAlD
Lansoprazole—ABCB1—islet of Langerhans—pancreatic cancer	0.000343	0.01	CbGeAlD
Lansoprazole—CYP3A4—digestive system—pancreatic cancer	0.000291	0.00849	CbGeAlD
Lansoprazole—CYP2D6—digestive system—pancreatic cancer	0.000286	0.00836	CbGeAlD
Lansoprazole—ABCB1—pancreas—pancreatic cancer	0.000241	0.00704	CbGeAlD
Lansoprazole—ABCB1—digestive system—pancreatic cancer	0.000206	0.00601	CbGeAlD
Lansoprazole—Weight increased—Doxorubicin—pancreatic cancer	6.06e-05	0.000315	CcSEcCtD
Lansoprazole—Epistaxis—Epirubicin—pancreatic cancer	6.05e-05	0.000314	CcSEcCtD
Lansoprazole—Pruritus—Gemcitabine—pancreatic cancer	6.05e-05	0.000314	CcSEcCtD
Lansoprazole—Infection—Docetaxel—pancreatic cancer	6.03e-05	0.000313	CcSEcCtD
Lansoprazole—Sinusitis—Epirubicin—pancreatic cancer	6.02e-05	0.000313	CcSEcCtD
Lansoprazole—Hyperglycaemia—Doxorubicin—pancreatic cancer	6.01e-05	0.000312	CcSEcCtD
Lansoprazole—Diarrhoea—Irinotecan—pancreatic cancer	6.01e-05	0.000312	CcSEcCtD
Lansoprazole—Agranulocytosis—Epirubicin—pancreatic cancer	5.99e-05	0.000311	CcSEcCtD
Lansoprazole—Pneumonia—Doxorubicin—pancreatic cancer	5.97e-05	0.00031	CcSEcCtD
Lansoprazole—Shock—Docetaxel—pancreatic cancer	5.97e-05	0.00031	CcSEcCtD
Lansoprazole—Nervous system disorder—Docetaxel—pancreatic cancer	5.95e-05	0.000309	CcSEcCtD
Lansoprazole—Pruritus—Fluorouracil—pancreatic cancer	5.95e-05	0.000309	CcSEcCtD
Lansoprazole—Thrombocytopenia—Docetaxel—pancreatic cancer	5.94e-05	0.000309	CcSEcCtD
Lansoprazole—Infestation NOS—Doxorubicin—pancreatic cancer	5.94e-05	0.000309	CcSEcCtD
Lansoprazole—Infestation—Doxorubicin—pancreatic cancer	5.94e-05	0.000309	CcSEcCtD
Lansoprazole—Tachycardia—Docetaxel—pancreatic cancer	5.92e-05	0.000308	CcSEcCtD
Lansoprazole—Skin disorder—Docetaxel—pancreatic cancer	5.89e-05	0.000306	CcSEcCtD
Lansoprazole—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	5.89e-05	0.000306	CcSEcCtD
Lansoprazole—Bradycardia—Epirubicin—pancreatic cancer	5.86e-05	0.000305	CcSEcCtD
Lansoprazole—Diarrhoea—Gemcitabine—pancreatic cancer	5.85e-05	0.000304	CcSEcCtD
Lansoprazole—Renal failure—Doxorubicin—pancreatic cancer	5.84e-05	0.000303	CcSEcCtD
Lansoprazole—Neuropathy peripheral—Doxorubicin—pancreatic cancer	5.82e-05	0.000302	CcSEcCtD
Lansoprazole—Dizziness—Irinotecan—pancreatic cancer	5.8e-05	0.000302	CcSEcCtD
Lansoprazole—Jaundice—Doxorubicin—pancreatic cancer	5.79e-05	0.000301	CcSEcCtD
Lansoprazole—Stomatitis—Doxorubicin—pancreatic cancer	5.79e-05	0.000301	CcSEcCtD
Lansoprazole—Anorexia—Docetaxel—pancreatic cancer	5.78e-05	0.000301	CcSEcCtD
Lansoprazole—Rhinitis—Epirubicin—pancreatic cancer	5.78e-05	0.0003	CcSEcCtD
Lansoprazole—Urinary tract infection—Doxorubicin—pancreatic cancer	5.77e-05	0.0003	CcSEcCtD
Lansoprazole—Conjunctivitis—Doxorubicin—pancreatic cancer	5.77e-05	0.0003	CcSEcCtD
Lansoprazole—Hepatitis—Epirubicin—pancreatic cancer	5.76e-05	0.000299	CcSEcCtD
Lansoprazole—Diarrhoea—Fluorouracil—pancreatic cancer	5.75e-05	0.000299	CcSEcCtD
Lansoprazole—Hypoaesthesia—Epirubicin—pancreatic cancer	5.73e-05	0.000298	CcSEcCtD
Lansoprazole—Pharyngitis—Epirubicin—pancreatic cancer	5.72e-05	0.000297	CcSEcCtD
Lansoprazole—Sweating—Doxorubicin—pancreatic cancer	5.69e-05	0.000296	CcSEcCtD
Lansoprazole—Urinary tract disorder—Epirubicin—pancreatic cancer	5.69e-05	0.000296	CcSEcCtD
Lansoprazole—Oedema peripheral—Epirubicin—pancreatic cancer	5.67e-05	0.000295	CcSEcCtD
Lansoprazole—Hypotension—Docetaxel—pancreatic cancer	5.67e-05	0.000295	CcSEcCtD
Lansoprazole—Haematuria—Doxorubicin—pancreatic cancer	5.66e-05	0.000294	CcSEcCtD
Lansoprazole—Connective tissue disorder—Epirubicin—pancreatic cancer	5.66e-05	0.000294	CcSEcCtD
Lansoprazole—Urethral disorder—Epirubicin—pancreatic cancer	5.65e-05	0.000293	CcSEcCtD
Lansoprazole—Hepatobiliary disease—Doxorubicin—pancreatic cancer	5.62e-05	0.000292	CcSEcCtD
Lansoprazole—Epistaxis—Doxorubicin—pancreatic cancer	5.6e-05	0.000291	CcSEcCtD
Lansoprazole—Vomiting—Irinotecan—pancreatic cancer	5.58e-05	0.00029	CcSEcCtD
Lansoprazole—Sinusitis—Doxorubicin—pancreatic cancer	5.57e-05	0.000289	CcSEcCtD
Lansoprazole—Dizziness—Fluorouracil—pancreatic cancer	5.56e-05	0.000289	CcSEcCtD
Lansoprazole—Visual impairment—Epirubicin—pancreatic cancer	5.55e-05	0.000288	CcSEcCtD
Lansoprazole—Agranulocytosis—Doxorubicin—pancreatic cancer	5.54e-05	0.000288	CcSEcCtD
Lansoprazole—Rash—Irinotecan—pancreatic cancer	5.53e-05	0.000288	CcSEcCtD
Lansoprazole—Dermatitis—Irinotecan—pancreatic cancer	5.53e-05	0.000287	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	5.53e-05	0.000287	CcSEcCtD
Lansoprazole—Headache—Irinotecan—pancreatic cancer	5.5e-05	0.000286	CcSEcCtD
Lansoprazole—Insomnia—Docetaxel—pancreatic cancer	5.49e-05	0.000285	CcSEcCtD
Lansoprazole—Paraesthesia—Docetaxel—pancreatic cancer	5.45e-05	0.000283	CcSEcCtD
Lansoprazole—Erythema multiforme—Epirubicin—pancreatic cancer	5.45e-05	0.000283	CcSEcCtD
Lansoprazole—Vomiting—Gemcitabine—pancreatic cancer	5.44e-05	0.000282	CcSEcCtD
Lansoprazole—Bradycardia—Doxorubicin—pancreatic cancer	5.43e-05	0.000282	CcSEcCtD
Lansoprazole—Dyspnoea—Docetaxel—pancreatic cancer	5.41e-05	0.000281	CcSEcCtD
Lansoprazole—Somnolence—Docetaxel—pancreatic cancer	5.39e-05	0.00028	CcSEcCtD
Lansoprazole—Rash—Gemcitabine—pancreatic cancer	5.39e-05	0.00028	CcSEcCtD
Lansoprazole—Dermatitis—Gemcitabine—pancreatic cancer	5.39e-05	0.00028	CcSEcCtD
Lansoprazole—Eye disorder—Epirubicin—pancreatic cancer	5.38e-05	0.00028	CcSEcCtD
Lansoprazole—Tinnitus—Epirubicin—pancreatic cancer	5.37e-05	0.000279	CcSEcCtD
Lansoprazole—Headache—Gemcitabine—pancreatic cancer	5.36e-05	0.000278	CcSEcCtD
Lansoprazole—Cardiac disorder—Epirubicin—pancreatic cancer	5.35e-05	0.000278	CcSEcCtD
Lansoprazole—Vomiting—Fluorouracil—pancreatic cancer	5.35e-05	0.000278	CcSEcCtD
Lansoprazole—Rhinitis—Doxorubicin—pancreatic cancer	5.34e-05	0.000278	CcSEcCtD
Lansoprazole—Dyspepsia—Docetaxel—pancreatic cancer	5.34e-05	0.000278	CcSEcCtD
Lansoprazole—Hepatitis—Doxorubicin—pancreatic cancer	5.33e-05	0.000277	CcSEcCtD
Lansoprazole—Hypoaesthesia—Doxorubicin—pancreatic cancer	5.3e-05	0.000276	CcSEcCtD
Lansoprazole—Rash—Fluorouracil—pancreatic cancer	5.3e-05	0.000275	CcSEcCtD
Lansoprazole—Dermatitis—Fluorouracil—pancreatic cancer	5.3e-05	0.000275	CcSEcCtD
Lansoprazole—Pharyngitis—Doxorubicin—pancreatic cancer	5.29e-05	0.000275	CcSEcCtD
Lansoprazole—Decreased appetite—Docetaxel—pancreatic cancer	5.27e-05	0.000274	CcSEcCtD
Lansoprazole—Headache—Fluorouracil—pancreatic cancer	5.27e-05	0.000274	CcSEcCtD
Lansoprazole—Urinary tract disorder—Doxorubicin—pancreatic cancer	5.26e-05	0.000274	CcSEcCtD
Lansoprazole—Oedema peripheral—Doxorubicin—pancreatic cancer	5.25e-05	0.000273	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Docetaxel—pancreatic cancer	5.24e-05	0.000272	CcSEcCtD
Lansoprazole—Connective tissue disorder—Doxorubicin—pancreatic cancer	5.24e-05	0.000272	CcSEcCtD
Lansoprazole—Fatigue—Docetaxel—pancreatic cancer	5.23e-05	0.000272	CcSEcCtD
Lansoprazole—Angiopathy—Epirubicin—pancreatic cancer	5.23e-05	0.000272	CcSEcCtD
Lansoprazole—Urethral disorder—Doxorubicin—pancreatic cancer	5.22e-05	0.000271	CcSEcCtD
Lansoprazole—Nausea—Irinotecan—pancreatic cancer	5.21e-05	0.000271	CcSEcCtD
Lansoprazole—Immune system disorder—Epirubicin—pancreatic cancer	5.2e-05	0.00027	CcSEcCtD
Lansoprazole—Mediastinal disorder—Epirubicin—pancreatic cancer	5.19e-05	0.00027	CcSEcCtD
Lansoprazole—Constipation—Docetaxel—pancreatic cancer	5.19e-05	0.00027	CcSEcCtD
Lansoprazole—Pain—Docetaxel—pancreatic cancer	5.19e-05	0.00027	CcSEcCtD
Lansoprazole—Chills—Epirubicin—pancreatic cancer	5.17e-05	0.000269	CcSEcCtD
Lansoprazole—Arrhythmia—Epirubicin—pancreatic cancer	5.15e-05	0.000267	CcSEcCtD
Lansoprazole—Visual impairment—Doxorubicin—pancreatic cancer	5.14e-05	0.000267	CcSEcCtD
Lansoprazole—Alopecia—Epirubicin—pancreatic cancer	5.09e-05	0.000264	CcSEcCtD
Lansoprazole—Nausea—Gemcitabine—pancreatic cancer	5.08e-05	0.000264	CcSEcCtD
Lansoprazole—Mental disorder—Epirubicin—pancreatic cancer	5.05e-05	0.000262	CcSEcCtD
Lansoprazole—Erythema multiforme—Doxorubicin—pancreatic cancer	5.04e-05	0.000262	CcSEcCtD
Lansoprazole—Malnutrition—Epirubicin—pancreatic cancer	5.01e-05	0.000261	CcSEcCtD
Lansoprazole—Erythema—Epirubicin—pancreatic cancer	5.01e-05	0.000261	CcSEcCtD
Lansoprazole—Feeling abnormal—Docetaxel—pancreatic cancer	5e-05	0.00026	CcSEcCtD
Lansoprazole—Nausea—Fluorouracil—pancreatic cancer	4.99e-05	0.000259	CcSEcCtD
Lansoprazole—Eye disorder—Doxorubicin—pancreatic cancer	4.98e-05	0.000259	CcSEcCtD
Lansoprazole—Tinnitus—Doxorubicin—pancreatic cancer	4.97e-05	0.000258	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Docetaxel—pancreatic cancer	4.96e-05	0.000258	CcSEcCtD
Lansoprazole—Cardiac disorder—Doxorubicin—pancreatic cancer	4.95e-05	0.000257	CcSEcCtD
Lansoprazole—Flatulence—Epirubicin—pancreatic cancer	4.94e-05	0.000257	CcSEcCtD
Lansoprazole—Tension—Epirubicin—pancreatic cancer	4.92e-05	0.000256	CcSEcCtD
Lansoprazole—Dysgeusia—Epirubicin—pancreatic cancer	4.91e-05	0.000255	CcSEcCtD
Lansoprazole—Nervousness—Epirubicin—pancreatic cancer	4.87e-05	0.000253	CcSEcCtD
Lansoprazole—Back pain—Epirubicin—pancreatic cancer	4.85e-05	0.000252	CcSEcCtD
Lansoprazole—Angiopathy—Doxorubicin—pancreatic cancer	4.84e-05	0.000251	CcSEcCtD
Lansoprazole—Muscle spasms—Epirubicin—pancreatic cancer	4.82e-05	0.000251	CcSEcCtD
Lansoprazole—Immune system disorder—Doxorubicin—pancreatic cancer	4.81e-05	0.00025	CcSEcCtD
Lansoprazole—Mediastinal disorder—Doxorubicin—pancreatic cancer	4.8e-05	0.00025	CcSEcCtD
Lansoprazole—Abdominal pain—Docetaxel—pancreatic cancer	4.8e-05	0.000249	CcSEcCtD
Lansoprazole—Body temperature increased—Docetaxel—pancreatic cancer	4.8e-05	0.000249	CcSEcCtD
Lansoprazole—Chills—Doxorubicin—pancreatic cancer	4.78e-05	0.000249	CcSEcCtD
Lansoprazole—Arrhythmia—Doxorubicin—pancreatic cancer	4.76e-05	0.000247	CcSEcCtD
Lansoprazole—Vision blurred—Epirubicin—pancreatic cancer	4.73e-05	0.000246	CcSEcCtD
Lansoprazole—Alopecia—Doxorubicin—pancreatic cancer	4.71e-05	0.000245	CcSEcCtD
Lansoprazole—Mental disorder—Doxorubicin—pancreatic cancer	4.67e-05	0.000243	CcSEcCtD
Lansoprazole—Ill-defined disorder—Epirubicin—pancreatic cancer	4.65e-05	0.000242	CcSEcCtD
Lansoprazole—Erythema—Doxorubicin—pancreatic cancer	4.64e-05	0.000241	CcSEcCtD
Lansoprazole—Malnutrition—Doxorubicin—pancreatic cancer	4.64e-05	0.000241	CcSEcCtD
Lansoprazole—Anaemia—Epirubicin—pancreatic cancer	4.63e-05	0.000241	CcSEcCtD
Lansoprazole—Agitation—Epirubicin—pancreatic cancer	4.61e-05	0.000239	CcSEcCtD
Lansoprazole—Flatulence—Doxorubicin—pancreatic cancer	4.57e-05	0.000238	CcSEcCtD
Lansoprazole—Tension—Doxorubicin—pancreatic cancer	4.55e-05	0.000237	CcSEcCtD
Lansoprazole—Dysgeusia—Doxorubicin—pancreatic cancer	4.54e-05	0.000236	CcSEcCtD
Lansoprazole—Malaise—Epirubicin—pancreatic cancer	4.52e-05	0.000235	CcSEcCtD
Lansoprazole—Nervousness—Doxorubicin—pancreatic cancer	4.51e-05	0.000234	CcSEcCtD
Lansoprazole—Vertigo—Epirubicin—pancreatic cancer	4.51e-05	0.000234	CcSEcCtD
Lansoprazole—Syncope—Epirubicin—pancreatic cancer	4.5e-05	0.000234	CcSEcCtD
Lansoprazole—Leukopenia—Epirubicin—pancreatic cancer	4.49e-05	0.000233	CcSEcCtD
Lansoprazole—Back pain—Doxorubicin—pancreatic cancer	4.49e-05	0.000233	CcSEcCtD
Lansoprazole—Hypersensitivity—Docetaxel—pancreatic cancer	4.47e-05	0.000232	CcSEcCtD
Lansoprazole—Muscle spasms—Doxorubicin—pancreatic cancer	4.46e-05	0.000232	CcSEcCtD
Lansoprazole—Palpitations—Epirubicin—pancreatic cancer	4.43e-05	0.00023	CcSEcCtD
Lansoprazole—Loss of consciousness—Epirubicin—pancreatic cancer	4.41e-05	0.000229	CcSEcCtD
Lansoprazole—Cough—Epirubicin—pancreatic cancer	4.38e-05	0.000227	CcSEcCtD
Lansoprazole—Vision blurred—Doxorubicin—pancreatic cancer	4.37e-05	0.000227	CcSEcCtD
Lansoprazole—Asthenia—Docetaxel—pancreatic cancer	4.35e-05	0.000226	CcSEcCtD
Lansoprazole—Convulsion—Epirubicin—pancreatic cancer	4.34e-05	0.000226	CcSEcCtD
Lansoprazole—Hypertension—Epirubicin—pancreatic cancer	4.33e-05	0.000225	CcSEcCtD
Lansoprazole—Ill-defined disorder—Doxorubicin—pancreatic cancer	4.31e-05	0.000224	CcSEcCtD
Lansoprazole—Pruritus—Docetaxel—pancreatic cancer	4.29e-05	0.000223	CcSEcCtD
Lansoprazole—Anaemia—Doxorubicin—pancreatic cancer	4.29e-05	0.000223	CcSEcCtD
Lansoprazole—Myalgia—Epirubicin—pancreatic cancer	4.27e-05	0.000222	CcSEcCtD
Lansoprazole—Chest pain—Epirubicin—pancreatic cancer	4.27e-05	0.000222	CcSEcCtD
Lansoprazole—Arthralgia—Epirubicin—pancreatic cancer	4.27e-05	0.000222	CcSEcCtD
Lansoprazole—Agitation—Doxorubicin—pancreatic cancer	4.26e-05	0.000222	CcSEcCtD
Lansoprazole—Anxiety—Epirubicin—pancreatic cancer	4.25e-05	0.000221	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	4.24e-05	0.00022	CcSEcCtD
Lansoprazole—Discomfort—Epirubicin—pancreatic cancer	4.22e-05	0.000219	CcSEcCtD
Lansoprazole—Malaise—Doxorubicin—pancreatic cancer	4.18e-05	0.000217	CcSEcCtD
Lansoprazole—Dry mouth—Epirubicin—pancreatic cancer	4.18e-05	0.000217	CcSEcCtD
Lansoprazole—Vertigo—Doxorubicin—pancreatic cancer	4.17e-05	0.000217	CcSEcCtD
Lansoprazole—Syncope—Doxorubicin—pancreatic cancer	4.16e-05	0.000216	CcSEcCtD
Lansoprazole—Leukopenia—Doxorubicin—pancreatic cancer	4.15e-05	0.000216	CcSEcCtD
Lansoprazole—Diarrhoea—Docetaxel—pancreatic cancer	4.15e-05	0.000216	CcSEcCtD
Lansoprazole—Confusional state—Epirubicin—pancreatic cancer	4.13e-05	0.000214	CcSEcCtD
Lansoprazole—Palpitations—Doxorubicin—pancreatic cancer	4.1e-05	0.000213	CcSEcCtD
Lansoprazole—Anaphylactic shock—Epirubicin—pancreatic cancer	4.09e-05	0.000213	CcSEcCtD
Lansoprazole—Oedema—Epirubicin—pancreatic cancer	4.09e-05	0.000213	CcSEcCtD
Lansoprazole—Loss of consciousness—Doxorubicin—pancreatic cancer	4.08e-05	0.000212	CcSEcCtD
Lansoprazole—Infection—Epirubicin—pancreatic cancer	4.07e-05	0.000211	CcSEcCtD
Lansoprazole—Cough—Doxorubicin—pancreatic cancer	4.05e-05	0.00021	CcSEcCtD
Lansoprazole—Shock—Epirubicin—pancreatic cancer	4.03e-05	0.000209	CcSEcCtD
Lansoprazole—Convulsion—Doxorubicin—pancreatic cancer	4.02e-05	0.000209	CcSEcCtD
Lansoprazole—Nervous system disorder—Epirubicin—pancreatic cancer	4.01e-05	0.000209	CcSEcCtD
Lansoprazole—Dizziness—Docetaxel—pancreatic cancer	4.01e-05	0.000208	CcSEcCtD
Lansoprazole—Thrombocytopenia—Epirubicin—pancreatic cancer	4.01e-05	0.000208	CcSEcCtD
Lansoprazole—Hypertension—Doxorubicin—pancreatic cancer	4.01e-05	0.000208	CcSEcCtD
Lansoprazole—Tachycardia—Epirubicin—pancreatic cancer	3.99e-05	0.000208	CcSEcCtD
Lansoprazole—Skin disorder—Epirubicin—pancreatic cancer	3.98e-05	0.000207	CcSEcCtD
Lansoprazole—Hyperhidrosis—Epirubicin—pancreatic cancer	3.96e-05	0.000206	CcSEcCtD
Lansoprazole—Myalgia—Doxorubicin—pancreatic cancer	3.95e-05	0.000205	CcSEcCtD
Lansoprazole—Arthralgia—Doxorubicin—pancreatic cancer	3.95e-05	0.000205	CcSEcCtD
Lansoprazole—Chest pain—Doxorubicin—pancreatic cancer	3.95e-05	0.000205	CcSEcCtD
Lansoprazole—Anxiety—Doxorubicin—pancreatic cancer	3.94e-05	0.000205	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	3.92e-05	0.000204	CcSEcCtD
Lansoprazole—Discomfort—Doxorubicin—pancreatic cancer	3.9e-05	0.000203	CcSEcCtD
Lansoprazole—Anorexia—Epirubicin—pancreatic cancer	3.9e-05	0.000203	CcSEcCtD
Lansoprazole—Dry mouth—Doxorubicin—pancreatic cancer	3.86e-05	0.000201	CcSEcCtD
Lansoprazole—Vomiting—Docetaxel—pancreatic cancer	3.86e-05	0.0002	CcSEcCtD
Lansoprazole—Rash—Docetaxel—pancreatic cancer	3.83e-05	0.000199	CcSEcCtD
Lansoprazole—Hypotension—Epirubicin—pancreatic cancer	3.82e-05	0.000199	CcSEcCtD
Lansoprazole—Dermatitis—Docetaxel—pancreatic cancer	3.82e-05	0.000199	CcSEcCtD
Lansoprazole—Confusional state—Doxorubicin—pancreatic cancer	3.82e-05	0.000198	CcSEcCtD
Lansoprazole—Headache—Docetaxel—pancreatic cancer	3.8e-05	0.000198	CcSEcCtD
Lansoprazole—Anaphylactic shock—Doxorubicin—pancreatic cancer	3.79e-05	0.000197	CcSEcCtD
Lansoprazole—Oedema—Doxorubicin—pancreatic cancer	3.79e-05	0.000197	CcSEcCtD
Lansoprazole—Infection—Doxorubicin—pancreatic cancer	3.76e-05	0.000195	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	3.73e-05	0.000194	CcSEcCtD
Lansoprazole—Shock—Doxorubicin—pancreatic cancer	3.73e-05	0.000194	CcSEcCtD
Lansoprazole—Nervous system disorder—Doxorubicin—pancreatic cancer	3.71e-05	0.000193	CcSEcCtD
Lansoprazole—Thrombocytopenia—Doxorubicin—pancreatic cancer	3.71e-05	0.000193	CcSEcCtD
Lansoprazole—Insomnia—Epirubicin—pancreatic cancer	3.7e-05	0.000192	CcSEcCtD
Lansoprazole—Tachycardia—Doxorubicin—pancreatic cancer	3.7e-05	0.000192	CcSEcCtD
Lansoprazole—Skin disorder—Doxorubicin—pancreatic cancer	3.68e-05	0.000191	CcSEcCtD
Lansoprazole—Paraesthesia—Epirubicin—pancreatic cancer	3.68e-05	0.000191	CcSEcCtD
Lansoprazole—Hyperhidrosis—Doxorubicin—pancreatic cancer	3.66e-05	0.00019	CcSEcCtD
Lansoprazole—Dyspnoea—Epirubicin—pancreatic cancer	3.65e-05	0.00019	CcSEcCtD
Lansoprazole—Somnolence—Epirubicin—pancreatic cancer	3.64e-05	0.000189	CcSEcCtD
Lansoprazole—Anorexia—Doxorubicin—pancreatic cancer	3.61e-05	0.000188	CcSEcCtD
Lansoprazole—Nausea—Docetaxel—pancreatic cancer	3.6e-05	0.000187	CcSEcCtD
Lansoprazole—Dyspepsia—Epirubicin—pancreatic cancer	3.6e-05	0.000187	CcSEcCtD
Lansoprazole—Decreased appetite—Epirubicin—pancreatic cancer	3.56e-05	0.000185	CcSEcCtD
Lansoprazole—Hypotension—Doxorubicin—pancreatic cancer	3.54e-05	0.000184	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Epirubicin—pancreatic cancer	3.53e-05	0.000184	CcSEcCtD
Lansoprazole—Fatigue—Epirubicin—pancreatic cancer	3.53e-05	0.000183	CcSEcCtD
Lansoprazole—Pain—Epirubicin—pancreatic cancer	3.5e-05	0.000182	CcSEcCtD
Lansoprazole—Constipation—Epirubicin—pancreatic cancer	3.5e-05	0.000182	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	3.45e-05	0.000179	CcSEcCtD
Lansoprazole—Insomnia—Doxorubicin—pancreatic cancer	3.43e-05	0.000178	CcSEcCtD
Lansoprazole—Paraesthesia—Doxorubicin—pancreatic cancer	3.4e-05	0.000177	CcSEcCtD
Lansoprazole—Dyspnoea—Doxorubicin—pancreatic cancer	3.38e-05	0.000175	CcSEcCtD
Lansoprazole—Feeling abnormal—Epirubicin—pancreatic cancer	3.37e-05	0.000175	CcSEcCtD
Lansoprazole—Somnolence—Doxorubicin—pancreatic cancer	3.37e-05	0.000175	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Epirubicin—pancreatic cancer	3.35e-05	0.000174	CcSEcCtD
Lansoprazole—Dyspepsia—Doxorubicin—pancreatic cancer	3.33e-05	0.000173	CcSEcCtD
Lansoprazole—Decreased appetite—Doxorubicin—pancreatic cancer	3.29e-05	0.000171	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	3.27e-05	0.00017	CcSEcCtD
Lansoprazole—Fatigue—Doxorubicin—pancreatic cancer	3.26e-05	0.00017	CcSEcCtD
Lansoprazole—Urticaria—Epirubicin—pancreatic cancer	3.25e-05	0.000169	CcSEcCtD
Lansoprazole—Constipation—Doxorubicin—pancreatic cancer	3.24e-05	0.000168	CcSEcCtD
Lansoprazole—Pain—Doxorubicin—pancreatic cancer	3.24e-05	0.000168	CcSEcCtD
Lansoprazole—Body temperature increased—Epirubicin—pancreatic cancer	3.24e-05	0.000168	CcSEcCtD
Lansoprazole—Abdominal pain—Epirubicin—pancreatic cancer	3.24e-05	0.000168	CcSEcCtD
Lansoprazole—Feeling abnormal—Doxorubicin—pancreatic cancer	3.12e-05	0.000162	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Doxorubicin—pancreatic cancer	3.1e-05	0.000161	CcSEcCtD
Lansoprazole—Hypersensitivity—Epirubicin—pancreatic cancer	3.02e-05	0.000157	CcSEcCtD
Lansoprazole—Urticaria—Doxorubicin—pancreatic cancer	3.01e-05	0.000156	CcSEcCtD
Lansoprazole—Body temperature increased—Doxorubicin—pancreatic cancer	2.99e-05	0.000156	CcSEcCtD
Lansoprazole—Abdominal pain—Doxorubicin—pancreatic cancer	2.99e-05	0.000156	CcSEcCtD
Lansoprazole—Asthenia—Epirubicin—pancreatic cancer	2.94e-05	0.000153	CcSEcCtD
Lansoprazole—Pruritus—Epirubicin—pancreatic cancer	2.9e-05	0.00015	CcSEcCtD
Lansoprazole—Diarrhoea—Epirubicin—pancreatic cancer	2.8e-05	0.000146	CcSEcCtD
Lansoprazole—Hypersensitivity—Doxorubicin—pancreatic cancer	2.79e-05	0.000145	CcSEcCtD
Lansoprazole—Asthenia—Doxorubicin—pancreatic cancer	2.72e-05	0.000141	CcSEcCtD
Lansoprazole—Dizziness—Epirubicin—pancreatic cancer	2.71e-05	0.000141	CcSEcCtD
Lansoprazole—Pruritus—Doxorubicin—pancreatic cancer	2.68e-05	0.000139	CcSEcCtD
Lansoprazole—Vomiting—Epirubicin—pancreatic cancer	2.6e-05	0.000135	CcSEcCtD
Lansoprazole—Diarrhoea—Doxorubicin—pancreatic cancer	2.59e-05	0.000135	CcSEcCtD
Lansoprazole—Rash—Epirubicin—pancreatic cancer	2.58e-05	0.000134	CcSEcCtD
Lansoprazole—Dermatitis—Epirubicin—pancreatic cancer	2.58e-05	0.000134	CcSEcCtD
Lansoprazole—Headache—Epirubicin—pancreatic cancer	2.56e-05	0.000133	CcSEcCtD
Lansoprazole—Dizziness—Doxorubicin—pancreatic cancer	2.5e-05	0.00013	CcSEcCtD
Lansoprazole—Nausea—Epirubicin—pancreatic cancer	2.43e-05	0.000126	CcSEcCtD
Lansoprazole—Vomiting—Doxorubicin—pancreatic cancer	2.41e-05	0.000125	CcSEcCtD
Lansoprazole—Rash—Doxorubicin—pancreatic cancer	2.39e-05	0.000124	CcSEcCtD
Lansoprazole—Dermatitis—Doxorubicin—pancreatic cancer	2.39e-05	0.000124	CcSEcCtD
Lansoprazole—Headache—Doxorubicin—pancreatic cancer	2.37e-05	0.000123	CcSEcCtD
Lansoprazole—Nausea—Doxorubicin—pancreatic cancer	2.25e-05	0.000117	CcSEcCtD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	1.53e-05	0.000185	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—TYMP—pancreatic cancer	1.52e-05	0.000184	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—TYMS—pancreatic cancer	1.51e-05	0.000184	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PRSS1—pancreatic cancer	1.51e-05	0.000183	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PRSS1—pancreatic cancer	1.5e-05	0.000182	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	1.49e-05	0.00018	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	1.47e-05	0.000178	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—CD44—pancreatic cancer	1.44e-05	0.000175	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	1.44e-05	0.000174	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ARG2—pancreatic cancer	1.43e-05	0.000173	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.41e-05	0.000171	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—APOE—pancreatic cancer	1.41e-05	0.000171	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.4e-05	0.000169	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—TYMP—pancreatic cancer	1.4e-05	0.000169	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ARG2—pancreatic cancer	1.39e-05	0.000169	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—GCG—pancreatic cancer	1.38e-05	0.000167	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.33e-05	0.000162	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	1.33e-05	0.000161	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ARG2—pancreatic cancer	1.31e-05	0.000159	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CD44—pancreatic cancer	1.31e-05	0.000159	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ARG2—pancreatic cancer	1.3e-05	0.000157	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—STK11—pancreatic cancer	1.3e-05	0.000157	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	1.3e-05	0.000157	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PRSS1—pancreatic cancer	1.28e-05	0.000155	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PIK3CG—pancreatic cancer	1.27e-05	0.000154	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—GCG—pancreatic cancer	1.26e-05	0.000152	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.26e-05	0.000152	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—TYMP—pancreatic cancer	1.25e-05	0.000151	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—APOE—pancreatic cancer	1.23e-05	0.000149	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PPARG—pancreatic cancer	1.23e-05	0.000149	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GLP1R—pancreatic cancer	1.23e-05	0.000149	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.22e-05	0.000148	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—TYMP—pancreatic cancer	1.22e-05	0.000147	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—DPYD—pancreatic cancer	1.21e-05	0.000146	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1.19e-05	0.000145	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1.19e-05	0.000144	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—STK11—pancreatic cancer	1.18e-05	0.000143	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.17e-05	0.000141	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.15e-05	0.00014	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—TYMP—pancreatic cancer	1.15e-05	0.000139	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—SLC2A2—pancreatic cancer	1.15e-05	0.000139	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—TYMP—pancreatic cancer	1.14e-05	0.000138	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.13e-05	0.000137	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GLP1R—pancreatic cancer	1.12e-05	0.000136	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PIK3CD—pancreatic cancer	1.12e-05	0.000136	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—TYMS—pancreatic cancer	1.12e-05	0.000135	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PIK3CG—pancreatic cancer	1.11e-05	0.000135	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.11e-05	0.000135	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ARG2—pancreatic cancer	1.11e-05	0.000135	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—DPYD—pancreatic cancer	1.11e-05	0.000134	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.1e-05	0.000134	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.09e-05	0.000133	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PPARG—pancreatic cancer	1.07e-05	0.00013	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	1.05e-05	0.000127	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.04e-05	0.000126	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.03e-05	0.000125	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—TYMS—pancreatic cancer	1.02e-05	0.000123	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.01e-05	0.000123	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GLP1R—pancreatic cancer	1e-05	0.000122	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1e-05	0.000122	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	9.96e-06	0.000121	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PRSS1—pancreatic cancer	9.88e-06	0.00012	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—DPYD—pancreatic cancer	9.88e-06	0.00012	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GLP1R—pancreatic cancer	9.8e-06	0.000119	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	9.8e-06	0.000119	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PIK3CD—pancreatic cancer	9.77e-06	0.000118	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PIK3CB—pancreatic cancer	9.75e-06	0.000118	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—TYMP—pancreatic cancer	9.71e-06	0.000118	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PTGS2—pancreatic cancer	9.66e-06	0.000117	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—DPYD—pancreatic cancer	9.64e-06	0.000117	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	9.37e-06	0.000114	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	9.37e-06	0.000114	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	9.28e-06	0.000112	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GLP1R—pancreatic cancer	9.23e-06	0.000112	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GLP1R—pancreatic cancer	9.15e-06	0.000111	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—SLC2A2—pancreatic cancer	9.15e-06	0.000111	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	9.14e-06	0.000111	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—DPYD—pancreatic cancer	9.08e-06	0.00011	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—APOE—pancreatic cancer	9.08e-06	0.00011	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—DPYD—pancreatic cancer	9.01e-06	0.000109	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	8.95e-06	0.000108	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CD44—pancreatic cancer	8.87e-06	0.000107	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	8.69e-06	0.000105	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	8.62e-06	0.000104	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	8.61e-06	0.000104	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	8.6e-06	0.000104	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ARG2—pancreatic cancer	8.57e-06	0.000104	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	8.55e-06	0.000104	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PIK3CB—pancreatic cancer	8.52e-06	0.000103	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GCG—pancreatic cancer	8.5e-06	0.000103	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	8.46e-06	0.000102	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PTGS2—pancreatic cancer	8.44e-06	0.000102	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PTEN—pancreatic cancer	8.42e-06	0.000102	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	8.27e-06	0.0001	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—APOE—pancreatic cancer	8.26e-06	0.0001	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PIK3CG—pancreatic cancer	8.2e-06	9.93e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	8.16e-06	9.89e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	8.15e-06	9.88e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CD44—pancreatic cancer	8.13e-06	9.85e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	8.01e-06	9.7e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—STK11—pancreatic cancer	8e-06	9.69e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.96e-06	9.65e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PPARG—pancreatic cancer	7.91e-06	9.59e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.89e-06	9.56e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GLP1R—pancreatic cancer	7.82e-06	9.48e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GCG—pancreatic cancer	7.8e-06	9.45e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—DPYD—pancreatic cancer	7.7e-06	9.33e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	7.51e-06	9.09e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—TYMP—pancreatic cancer	7.49e-06	9.08e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PIK3CG—pancreatic cancer	7.46e-06	9.04e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.44e-06	9.01e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PTEN—pancreatic cancer	7.36e-06	8.92e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—STK11—pancreatic cancer	7.33e-06	8.88e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	7.3e-06	8.85e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CD44—pancreatic cancer	7.26e-06	8.8e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	7.23e-06	8.76e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PIK3CD—pancreatic cancer	7.21e-06	8.73e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PPARG—pancreatic cancer	7.2e-06	8.72e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.11e-06	8.61e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CD44—pancreatic cancer	7.08e-06	8.58e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.04e-06	8.53e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	6.98e-06	8.45e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GCG—pancreatic cancer	6.96e-06	8.43e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.88e-06	8.34e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—TYMS—pancreatic cancer	6.88e-06	8.33e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GCG—pancreatic cancer	6.79e-06	8.23e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CD44—pancreatic cancer	6.68e-06	8.09e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CD44—pancreatic cancer	6.62e-06	8.02e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PIK3CD—pancreatic cancer	6.56e-06	7.94e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—STK11—pancreatic cancer	6.54e-06	7.93e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.48e-06	7.85e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.42e-06	7.78e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GCG—pancreatic cancer	6.4e-06	7.76e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—STK11—pancreatic cancer	6.39e-06	7.74e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	6.35e-06	7.7e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GCG—pancreatic cancer	6.35e-06	7.69e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—TYMS—pancreatic cancer	6.31e-06	7.64e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PIK3CB—pancreatic cancer	6.28e-06	7.61e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PTGS2—pancreatic cancer	6.22e-06	7.54e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.14e-06	7.44e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GLP1R—pancreatic cancer	6.04e-06	7.32e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—STK11—pancreatic cancer	6.02e-06	7.29e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—STK11—pancreatic cancer	5.97e-06	7.23e-05	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PIK3CA—pancreatic cancer	5.94e-06	7.2e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—DPYD—pancreatic cancer	5.94e-06	7.2e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PIK3CB—pancreatic cancer	5.71e-06	6.92e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PTGS2—pancreatic cancer	5.66e-06	6.86e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CD44—pancreatic cancer	5.66e-06	6.85e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	5.64e-06	6.83e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—TYMS—pancreatic cancer	5.63e-06	6.82e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.6e-06	6.79e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—APOE—pancreatic cancer	5.59e-06	6.78e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.54e-06	6.71e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—TYMS—pancreatic cancer	5.49e-06	6.66e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.49e-06	6.65e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PTEN—pancreatic cancer	5.43e-06	6.58e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GCG—pancreatic cancer	5.42e-06	6.57e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.29e-06	6.42e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PIK3CA—pancreatic cancer	5.19e-06	6.29e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—TYMS—pancreatic cancer	5.18e-06	6.27e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—TYMS—pancreatic cancer	5.13e-06	6.22e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—APOE—pancreatic cancer	5.13e-06	6.21e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—STK11—pancreatic cancer	5.1e-06	6.18e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PIK3CG—pancreatic cancer	5.05e-06	6.12e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PTEN—pancreatic cancer	4.94e-06	5.98e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PPARG—pancreatic cancer	4.87e-06	5.9e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.85e-06	5.88e-05	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—AKT1—pancreatic cancer	4.85e-06	5.88e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.79e-06	5.8e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	4.63e-06	5.61e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—APOE—pancreatic cancer	4.58e-06	5.55e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—APOE—pancreatic cancer	4.47e-06	5.41e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PPARG—pancreatic cancer	4.47e-06	5.41e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PIK3CD—pancreatic cancer	4.44e-06	5.38e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—TYMS—pancreatic cancer	4.39e-06	5.31e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CD44—pancreatic cancer	4.36e-06	5.29e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.33e-06	5.25e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—AKT1—pancreatic cancer	4.24e-06	5.14e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—APOE—pancreatic cancer	4.21e-06	5.1e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GCG—pancreatic cancer	4.18e-06	5.07e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—APOE—pancreatic cancer	4.17e-06	5.06e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	4.13e-06	5.01e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	4.07e-06	4.93e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PIK3CG—pancreatic cancer	4.03e-06	4.89e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PPARG—pancreatic cancer	3.99e-06	4.83e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.95e-06	4.79e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—STK11—pancreatic cancer	3.93e-06	4.77e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PPARG—pancreatic cancer	3.89e-06	4.72e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PIK3CB—pancreatic cancer	3.87e-06	4.69e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PTGS2—pancreatic cancer	3.83e-06	4.64e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PIK3CA—pancreatic cancer	3.83e-06	4.64e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	3.8e-06	4.6e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	3.77e-06	4.56e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PPARG—pancreatic cancer	3.67e-06	4.44e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PPARG—pancreatic cancer	3.64e-06	4.41e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	3.63e-06	4.4e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—APOE—pancreatic cancer	3.57e-06	4.32e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	3.55e-06	4.3e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PIK3CD—pancreatic cancer	3.54e-06	4.3e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PTGS2—pancreatic cancer	3.51e-06	4.26e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PIK3CA—pancreatic cancer	3.48e-06	4.22e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—TYMS—pancreatic cancer	3.38e-06	4.1e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.38e-06	4.09e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PTEN—pancreatic cancer	3.34e-06	4.05e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	3.34e-06	4.05e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	3.31e-06	4.01e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	3.22e-06	3.9e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	3.17e-06	3.84e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PTGS2—pancreatic cancer	3.14e-06	3.8e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—AKT1—pancreatic cancer	3.13e-06	3.79e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PPARG—pancreatic cancer	3.11e-06	3.76e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PIK3CB—pancreatic cancer	3.09e-06	3.74e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PTEN—pancreatic cancer	3.06e-06	3.71e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PTGS2—pancreatic cancer	3.06e-06	3.71e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	2.91e-06	3.53e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	2.89e-06	3.5e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PTGS2—pancreatic cancer	2.88e-06	3.5e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PTGS2—pancreatic cancer	2.86e-06	3.47e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—AKT1—pancreatic cancer	2.85e-06	3.45e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	2.83e-06	3.43e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOE—pancreatic cancer	2.75e-06	3.34e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PTEN—pancreatic cancer	2.74e-06	3.31e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PTEN—pancreatic cancer	2.67e-06	3.24e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PTEN—pancreatic cancer	2.52e-06	3.05e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PTEN—pancreatic cancer	2.49e-06	3.02e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.48e-06	3.01e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	2.47e-06	2.99e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PTGS2—pancreatic cancer	2.44e-06	2.96e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.4e-06	2.91e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PIK3CA—pancreatic cancer	2.36e-06	2.86e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	2.18e-06	2.65e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	2.16e-06	2.62e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PTEN—pancreatic cancer	2.13e-06	2.58e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	1.93e-06	2.34e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—AKT1—pancreatic cancer	1.93e-06	2.33e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.9e-06	2.31e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.89e-06	2.29e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PIK3CA—pancreatic cancer	1.88e-06	2.28e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.77e-06	2.15e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—AKT1—pancreatic cancer	1.77e-06	2.14e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.76e-06	2.13e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.64e-06	1.99e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—AKT1—pancreatic cancer	1.58e-06	1.91e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—AKT1—pancreatic cancer	1.54e-06	1.86e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	1.5e-06	1.82e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.45e-06	1.76e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.44e-06	1.74e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—AKT1—pancreatic cancer	1.23e-06	1.49e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.16e-06	1.41e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—AKT1—pancreatic cancer	9.48e-07	1.15e-05	CbGpPWpGaD
